AbbVie Inc. (NYSE:ABBV) is listed among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company is a key player in the pharmaceutical industry, with drugs like Skyrizi and Rinvoq driving revenue growth. AbbVie has increased dividend payouts by 310% since 2013 and has a strong cash position, with an operating cash flow of $16.4 billion. The company offers a quarterly dividend of $1.64 per share and has a dividend yield of 3.46%. While AbbVie shows potential as an investment, some AI stocks may offer greater upside.

Read more at Yahoo Finance: Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector